Four weeks of Ledipasvir/Sofosbuvir + Ribavirin with or without interferon gives very high and sustained cure rates in difficult to reach but easy to treat injecting drug users with chronic hepatitis C: final results of the 4WIDUC study
Authors:
- A.L.H. OevrehusAOA.L.H. Oevrehus
- H. KrarupHKH. Krarup
- I. BirkemoseIBI. Birkemose
- B. MössnerBMB. Mössner
- P.B. ChristensenPCP.B. Christensen
- 1 January 2017
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 66 (1) , S287